Serum Biomarkers Identification by Mass Spectrometry in High-Mortality Tumors

Cancer affects millions of people worldwide. Tumor mortality is substantially due to diagnosis at stages that are too late for therapies to be effective. Advances in screening methods have improved the early diagnosis, prognosis, and survival for some cancers. Several validated biomarkers are curren...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tessitore, Alessandra, Gaggiano, Agata, Cicciarelli, Germana, Verzella, Daniela, Capece, Daria, Fischietti, Mariafausta, Zazzeroni, Francesca, Alesse, Edoardo
Formato: Artigo
Lenguaje:Inglês
Publicado: Hindawi Publishing Corporation 2013
Materias:
Review Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3562576/
https://ncbi.nlm.nih.gov/pubmed/23401773
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/125858
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares